1-2 of 2
Faye M. Feller, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Imetelstat Is Effective Treatment for Patients with Intermediate-2 or High-Risk Myelofibrosis Who Have Relapsed on or Are Refractory to Janus Kinase Inhibitor Therapy: Results of a Phase 2 Randomized Study of Two Dose Levels

John Mascarenhas, MD, Rami S. Komrokji, MD, Michele Cavo, MD, Bruno Martino, MD, Dietger Niederwieser, MD, Andreas Reiter, MD, Bart L Scott, MD, Maria R. Baer, MD, Ronald Hoffman, MD, Olatoyosi Odenike, MD, Jacqueline Bussolari, PhD, Eugene Zhu, PhD, Fei Huang, PhD, Esther Rose, MD, Laurie Sherman, BSN, Souria Dougherty, BS, MBA, Faye M. Feller, MD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 685.
https://doi.org/10.1182/blood-2018-99-115163
Published: 2018
Journal Articles

The Addition of Radiation Therapy to Initial Treatment for Extramedullary Acute Myeloid Leukemia Does Not Offer a Survival Benefit When Added to Chemotherapy

Faye M. Feller, MD, Minal Patel, Sean M. Devlin, PhD, Molly Maloy, MA, Martin S. Tallman, MD, Miguel-Angel Perales, MD, Raajit K. Rampal, MD PhD
Journal: Blood
Blood (2014) 124 (21): 960.
https://doi.org/10.1182/blood.V124.21.960.960
Published: 2014